 |
|
 |
- May 11, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Biography |
|
|
Prof. Philip Barter
BIOGRAPHICAL NOTE
NAME
Philip John BARTER
ADDRESS
The Heart Research Institute
145 Missenden Road, Camperdown, Sydney
NSW, AUSTRALIA 2050
DEGREES AND
MD (Adelaide); PhD (ANU);
QUALIFICATIONS
FRACP
CURRENT POSITION
2003-
Director, The Heart Research Institute, Sydney and Professor of Medicine, University of Sydney
PAST POSITIONS
1986-1990
Deputy Director, Baker Research Institute,
Prahran, Victoria
1990- 1992
Professor of Cardiology and Head of the
Graduate School of Health and Medical Sciences,
The University of Wollongong.
1996- 2000
cademic Dean, Faculty of Medicine,
University of Adelaide
1992-2002
Professor of Cardiology,
The University of Adelaide
2001-2002
Director, Hanson Institute for Medical Research, Adelaide, Australia
SELECTED SCIENTIFIC AND PROFESSIONAL BODIES
International Atherosclerosis Society
2004- Executive Board, Member at large
International Task Force for Prevention of Coronary Heart Disease,
1998-2002 2003 Member, Board of Directors
The Metabolic Syndrome Institute
2003- Chairman
RESEARCH INTERESTS
Basic research
Plasma lipids and lipoproteins, specifically high density lipoproteins, the factors which regulate them and the mechanism by which they protect against coronary heart disease.
Clinical research
Clinical trials of lipid-lowering agents.
Currently a member of the Executive of the Steering Committees of two large international trials (the FIELD Study and the TNT Study) of the effects of lipid lowering on the prevention of coronary disease.
Chairman of the steering committee of a large morbidity and mortality endpoint trial on the effects of an oral CETP inhibitor
PUBLICATIONS
More than 180 research papers published in international peer-reviewed journals.
|
| |
List of presentations from this healthcare provider available on CMEonDiabetes :
 Management of the Metabolic Syndrome: The Evidence Base
english - 2005-04-14 - 27 minutes
|
|
|
|
|
| Social |
 |
| |
Let others know about this biography.
|
|
| Search our website |
|
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
|
|
